We also found that CDK4/6 inhibition by abemaciclib dramatically reduced YAP1 expressions while concurrently upregulating cleaved‐poly(ADP‐ribose) polymerase‐1 (PARP1) levels in tumor samples from saline‐treated mice. This evidence concerns the gene PARP1 and neoplasm.